glp 1 patch australia GLP-1 patches are worse than you think (I was wrong) Startups test patches for weight-loss

The goal is consistent protein intake, not a rigid schedule

Data from a Phase 2 clinical trial (n=338), published in August 2023, showed that in obese patients, 48 weeks of treatment resulted in an average weight reduction of 22.8% in the 8 mg group and 24.2% in the 12 mg group

The Medicare GLP-1 Bridge is a temporary pilot program that allows eligible Medicare recipients to get blockbuster anti-obesity medications like Wegovy and Zepbound for $50 a month

Another SURMOUNT-3 analysis208 demonstrated that tirzepatide improved health-related quality of life scores in obese/overweight adults, with greater benefits observed in those achieving higher weight loss thresholds and in those without baseline functional limitations

Ben observes, Patients are now coming in with a therapy already in mind, influenced by what theyve seen on social media or in advertisements